Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 39-43

  Cindolo, Luca ^a,b   Benvenuto, Giovanna ^a   Salavatore, Paola ^a,c   Pero, Raffaela ^a   Salvatore, Gaetano ^b   Mirone, Vincenzo ^b   Prezioso, Domenico ^b   Altieri, Vincenzo ^b   Bruni, Carmelo Bruno ^a,d   Chiariotti, Lorenzo ^a  

^a Ctro Endocrinol Ed Oncol S   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Dipto Biol e Patol Cell e Molec   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GALAPTIN; GALECTIN; GALECTIN 1; GALECTIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; FEMALE; GALECTIN 1; GALECTIN 3; HEMAGGLUTININS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RNA, MESSENGER; URETHRA; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0032964308     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<39::AID-IJC8>3.0.CO;2-E     Document Type: Article

References (27)

1. AKAHANI, S., INOHARA, H., NANGIA-MAKKER, P. and RAZ, A., Galectin-3 in tumor metastasis. Trends Glycosci. Glycotechnol., 9, 69-75 (1997).
2. BENVENUTO, G., CARPENTIERI, M.L., SALVATORE, P., CINDOLO, L., BRUNI, C.B. and CHIARIOTTI, L., Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol. cell. Biol., 16, 2736-2743 (1996).
3. CASTRONOVO, V., VAN DEN BRULE, F.A., JACKERS, P., CLAUSSE, N., LIU, F.-T., GILLET, C. and SOBEL, M.E., Decreased expression of galectin-3 is associated with progression of human breast cancer. J. Pathol., 179, 43-48 (1996).
4. CELIS, J.E., ØSTERGAARD, M., BASSE, B., CELIS, A., LAURIDSEN, J.B., RATZ, G.P., ANDERSEN, I., HEIN, B., WOLF, H., ØRNTOFT, T.F. and RASMUSSEN, H.H., Loss of adipocyte-type fatty acid binding protein and other biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res., 56, 4782-1790 (1997).
5. CHIARIOTTI, L., BERLINGIERI, M.T., BATTAGLIA, C., BENVENUTO, G., MARTELLI, M.L., SALVATORE, P., CHIAPPETTA, G., BRUNI, C.B. and FUSCO, A., Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors. Int. J. Cancer, 64, 171-175 (1995).
6. CHIARIOTTI, L., BERLINGIERI, M.T., DE ROSA, P., BATTAGLIA, C., BERGER, N., BRUNI, C.B. and FUSCO, A., Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene, 7, 2507-2511 (1992).
7. COLNOT, C., RIPOCHE, M.-A., FOWLIS, D., CANNON, V., SCAEROU, F., COOPER, D.N.W. and POIRIER, F., The role of galectins in mouse development. Trends Glycosci. Glycotechnol., 9, 31-40 (1997).
8. HARLOW, E. and LANE, D., Antibodies: a laboratory manual, p. 726, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1988).
9. HEDINGER, C., WILLIAMS, E.D. and SOBIN, L.H., The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63, 908-911 (1989).
10. HERMANEK, P. and SOBIN, L.H., TNM classification of malignant tumors, Springer, Berlin (1987).
11. HSU, H.M., RAINE, L. and FANGER, H., Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
12. KOMSTANTINOV, K.N., ROBBINS, B.A. and LIU, F.-T., Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Amer. J. Pathol., 148, 25-30 (1996).
13. LEFFLER, H., Introduction to galectins. Trennds Glycosci, Glycotechnol., 9, 9-19 (1997).
14. LOTAN, R., ITO, H., YASUI, W., YOKOZAKI, H., LOTAN, D. and TAHARA, E., Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int. J. Cancer, 56, 474-480 (1994).
15. ØSTERGAARD, M., RASMUSSEN, H.H., NIELSEN, H.V., VORUM, H., ØRNTOFT, T.F., WOLF, H. and CELIS, J.E., Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res., 57, 4111-1117 (1996).
16. PACE, K.E. and BAUM, L.G., Induction of T lymphocyte apoptosis: a novel function for galectin-1. Trends Glycosci. Glycotechnol., 9, 21-29 (1997).
17. PIENTA, J.K., NAIK, H., AKHTAR, A., YAMAZAKI, K., REPLOGLE, T.S., LEHR, J., DONAT, T.T., TAIT, L. HOGAN, V. and RAZ, A., Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J. nat. Cancer Inst., 87, 348-353 (1995).
18. RAZ, A., MEROMSKY, L., ZVIBEL, I. and LOTAN, R., Transformation-related changes in the expression of endogenous cell lectins. Int. J. Cancer, 39, 353-360 (1987).
19. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual, pp. 7.3-7.79, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
20. SANFORD, G.L. and HARRIS-HOOKER, S., Stimulation of vascular cell proliferation by beta-galactoside specific lectins. FASEB J., 4, 2912-2918 (1990).
21. SANJUÀN, X., FERNANDEZ, P.L., CASTELLS, A., CASTRONOVO, V., VAN DEN BRULE, F., LIU, F.-T., CARDESA, A. and CAMPO, E., Differential expression of galectin-3 and galectin-1 in colorectal cancer progression. Gastroenterology, 113, 1906-1915 (1997).
22. SKRINCOSKY, D., HALLEN, H.J. and BERNACKI, R.J., Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin binding proteins. Cancer Res., 53, 2667-2675 (1993).
23. VAN DEN BRULE, F.A., BERCHUCK, A., BAST, R.C., LIU, F.-T., GILLET, C., SOBEL, M.E. and CASTRONOVO, V., Differential expression of 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Europ. J. Cancer, 30, 1096-1099 (1994).
24. VYAKARNAM, A.S., DAGHER, S.F., WANG, J.L. and PATTERSON, R.J., Evidence for a role for galectin-1 in pre-mRNA splicing. Mol. cell. Biol., 17, 4730-4737 (1997).
25. WELLS, V. and MALLUCCI, L., Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytoslatic factor and cell growth regulator. Cell, 64, 91-97 (1991).
26. XU, X.C., EL-NAGGAR, A.K. and LOTAN, R., Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Amer. J. Pathol., 147, 815-822 (1995).
27. YAMAOKA, K., OHNO, S., KAWASAKI, H. and SUZUKI, K., Overexpression of a β-galactoside binding protein causes transformation of BALB3T3 fibroblast cells. Biochem. biophys. ReS. Comm., 179, 272-279 (1991).